Changquan Ling

5.1k total citations
155 papers, 3.7k citations indexed

About

Changquan Ling is a scholar working on Molecular Biology, Complementary and alternative medicine and Cancer Research. According to data from OpenAlex, Changquan Ling has authored 155 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 30 papers in Complementary and alternative medicine and 26 papers in Cancer Research. Recurrent topics in Changquan Ling's work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Natural product bioactivities and synthesis (14 papers) and Cancer Mechanisms and Therapy (14 papers). Changquan Ling is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Natural product bioactivities and synthesis (14 papers) and Cancer Mechanisms and Therapy (14 papers). Changquan Ling collaborates with scholars based in China, United States and India. Changquan Ling's co-authors include Binbin Cheng, Juan Du, Chen Ling, Xiaoqiang Yue, Xiaofeng Zhai, Qing-Hui Zhou, Hailiang Xin, Wanfu Lin, Xiaoyan Zhu and Min Li and has published in prestigious journals such as Advanced Materials, The Journal of Immunology and PLoS ONE.

In The Last Decade

Changquan Ling

150 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changquan Ling China 36 1.7k 584 498 448 402 155 3.7k
Wei Tang China 38 2.1k 1.2× 906 1.6× 317 0.6× 230 0.5× 945 2.4× 177 4.6k
Zhihao Liu China 35 1.6k 0.9× 273 0.5× 306 0.6× 255 0.6× 785 2.0× 239 4.1k
Jiunn‐Liang Ko Taiwan 39 2.3k 1.3× 648 1.1× 990 2.0× 369 0.8× 815 2.0× 184 4.7k
Yun Jung Lee South Korea 34 1.5k 0.9× 168 0.3× 342 0.7× 288 0.6× 311 0.8× 245 4.0k
Junling Yang China 34 1.6k 0.9× 355 0.6× 215 0.4× 384 0.9× 324 0.8× 109 3.2k
Di Wang China 35 2.8k 1.6× 496 0.8× 224 0.4× 212 0.5× 751 1.9× 221 4.8k
Hany A. Omar United Arab Emirates 36 1.4k 0.8× 343 0.6× 563 1.1× 166 0.4× 455 1.1× 126 4.0k
Robert Fürst Germany 32 1.4k 0.8× 302 0.5× 393 0.8× 250 0.6× 352 0.9× 119 3.7k

Countries citing papers authored by Changquan Ling

Since Specialization
Citations

This map shows the geographic impact of Changquan Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changquan Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changquan Ling more than expected).

Fields of papers citing papers by Changquan Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changquan Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changquan Ling. The network helps show where Changquan Ling may publish in the future.

Co-authorship network of co-authors of Changquan Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Changquan Ling. A scholar is included among the top collaborators of Changquan Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changquan Ling. Changquan Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Rui, et al.. (2025). HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization. Vaccines. 13(2). 182–182.
2.
Xu, Yannan, et al.. (2024). Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor. Journal of Integrative Medicine. 22(6). 709–718. 10 indexed citations
3.
Zong, Shaoqi, et al.. (2024). A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 525–542. 2 indexed citations
4.
Zhang, Jinbo, Yuqian Wang, Shufang Liang, et al.. (2024). Jiedu recipe, a compound Chinese herbal medicine, suppresses hepatocellular carcinoma metastasis by inhibiting the release of tumor-derived exosomes in a hypoxic microenvironment. Journal of Integrative Medicine. 22(6). 696–708. 10 indexed citations
5.
Yuan, Jiaying, et al.. (2023). Targeting tumor-derived exosome-mediated premetastatic niche formation: The metastasis-preventive value of traditional Chinese medicine. Cancer Letters. 567. 216261–216261. 13 indexed citations
6.
Liang, Shufang, Mingming Jin, Shu Li, et al.. (2023). Oleanolic acid inhibits hypoxic tumor-derived exosomes-induced premetastatic niche formation in hepatocellular carcinoma by targeting ERK1/2-NFκB signaling. Phytomedicine. 126. 155208–155208. 10 indexed citations
7.
Lin, Wanfu, Huan Wang, Shufang Liang, et al.. (2021). Effect and Molecular Mechanisms of Jiedu Recipe on Hypoxia-Induced Angiogenesis after Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 12 indexed citations
8.
Lin, Wanfu, Zifei Yin, Yong Zou, et al.. (2019). Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer. Evidence-based Complementary and Alternative Medicine. 2019. 1–10. 28 indexed citations
9.
Lin, Wanfu, Qing-Hui Zhou, Huan Wang, et al.. (2019). <p>Efficacy of complementary and integrative medicine on health-related quality of life in cancer patients: a systematic review and meta-analysis</p>. Cancer Management and Research. Volume 11. 6663–6680. 30 indexed citations
10.
Liang, Shufang, Yong Zou, Xiaolin Liu, et al.. (2018). The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways. Evidence-based Complementary and Alternative Medicine. 2018(1). 5629304–5629304. 13 indexed citations
11.
Lin, Wanfu, et al.. (2018). Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice. 2018. 1–10. 32 indexed citations
12.
Zhai, Xiaofeng, Xiaolin Liu, Feng Shen, Jia Fan, & Changquan Ling. (2018). Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer. 124(10). 2161–2168. 53 indexed citations
13.
Du, Juan, Dong Liu, Shufang Liang, et al.. (2017). Reduced MLH3 Expression in the Syndrome of Gan‐Shen Yin Deficiency in Patients with Different Diseases. Evidence-based Complementary and Alternative Medicine. 2017(1). 4109828–4109828. 5 indexed citations
14.
Lin, Wanfu, et al.. (2016). Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo. Oncology Reports. 36(2). 961–967. 66 indexed citations
15.
Feng, Yinglu, Chunbin Wang, Xiaorong Wang, et al.. (2015). Ginsenoside Rh1 Improves the Effect of Dexamethasone on Autoantibodies Production and Lymphoproliferation in MRL/lpr Mice. Evidence-based Complementary and Alternative Medicine. 2015. 1–8. 6 indexed citations
16.
Zhai, Xiaofeng, Zhe Chen, Bai Li, et al.. (2013). Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. Journal of Integrative Medicine. 11(2). 90–100. 82 indexed citations
17.
Yang, Geliang, et al.. (2013). Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology. Scandinavian Journal of Gastroenterology. 48(12). 1474–1483. 20 indexed citations
18.
Wang, Yuan, Chen Ling, Liujiang Song, et al.. (2012). Limitations of Encapsidation of Recombinant Self-Complementary Adeno-Associated Viral Genomes in Different Serotype Capsids and Their Quantitation. Human Gene Therapy Methods. 23(4). 225–233. 32 indexed citations
19.
20.
Ling, Changquan. (2003). Problems in cancer treatment and major research of integrative medicine. Journal of Chinese Integrative Medicine. 1(3). 168–170. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Tang Breakdown of academic impact, for papers by Zhihao Liu Breakdown of academic impact, for papers by Jiunn‐Liang Ko Breakdown of academic impact, for papers by Yun Jung Lee Breakdown of academic impact, for papers by Junling Yang Breakdown of academic impact, for papers by Di Wang Breakdown of academic impact, for papers by Hany A. Omar Breakdown of academic impact, for papers by Robert Fürst
Rankless by CCL
2026